Project Grant 2038460
Award Date
5/1/21
Completion Date
11/30/22
Dollars Obligated
$256K
Federal Agency
National Science Foundation
Awardee
Celldrop Inc. (NJXGWEBDRJH5)
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Laramie, WY 82071, USA
Similar Awards
The National Science Foundation awarded Ireprogram, LLC a $256,000 Project Grant under the Small Business Technology Transfer (STTR) program. The grant supports an STTR Phase I project to develop autologous hematopoietic stem cell production techniques to treat graft-versus-host disease. The STTR program seeks small business innovation research and development through public-private partnerships. This award will allow Ireprogram to research stem cell therapies with the goal of ending this...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $305,000 to Cellecho, Inc. supports the development of a microchip-based technology that leverages sound waves and electric fields to enable advanced cell engineering. The goal is to make complex cellular modifications, such as multiplex genome editing, more accessible for a wide range of users from students to experienced researchers. The technology aims to streamline processes...
Progenitor Inc. received a $255,750 Small Business Innovation Research Phase I Project Grant from the National Science Foundation to develop off-the-shelf immuno-compatible cell therapies. The grant was awarded on February 1, 2021 under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) and will fund the project through October 31, 2022 at Progenitor's facilities in Emigration Canyon, Utah. The NSF TIP program seeks to advance science and engineering research leading to...
Rattan Life Science Inc. received a $275,000 Project Grant award from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a platform for generating induced pluripotent stem cell-derived naïve CD4+ and CD8+ T cells with fidelity, reproducibility and scalability. The platform employs proprietary induced thymic epithelial cells to provide biologically relevant thymic positive selection signals during T cell differentiation,...
This National Science Foundation Project Grant of $100,000 supports research into polyelectrolyte multilayered surfaces for use in human mesenchymal stem/stromal cell manufacturing. The goal is to develop a scalable and controllable polymeric coating composed of natural polymers to improve the cell expansion process used in producing therapeutic human mesenchymal stromal cells. The coating is constructed via layer-by-layer assembly of collagen and heparin and has been shown to increase cell...
Nostopharma LLC was awarded a $256,000 Small Business Technology Transfer Phase I Project Grant from the National Science Foundation to develop a sustained-release, biodegradable nanoparticle drug delivery system for treatment of soft tissue trauma complications. Funded under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084), the 12-month project beginning March 1, 2022 aims to demonstrate in vitro and in vivo feasibility of modulating the ectopic bone microenvironment...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Laser Graphictronics LLC, a small disadvantaged business located in Columbia, MO, funds the development of "DigitFOAL", an early labor warning system for safe and successful foal delivery in the equine industry. The project leverages dual wearable photoplethysmography (PPG) sensors and a deep learning algorithm to monitor critical physiological signals in...
The National Science Foundation awarded Cytorecovery Inc. a $255,986 Small Business Technology Transfer Phase I Project Grant under the Engineering program (CFDA 47.041) on March 15, 2021. The grant funded the development of on-chip integration of sample preparation and monitoring capabilities with dielectrophoretic cell isolation techniques. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award...
Florica Therapeutics, Inc. was awarded a $275,678 Project Grant from the National Science Foundation Division of Industrial Innovation under the Engineering (47.041) federal grant program. The grant will support research from January 15, 2021 through December 31, 2021 to develop hypothalamus stem cell exosomes for the treatment of COVID-19. As part of its mission to improve lives and economic strength through engineering innovation, the NSF Engineering program aims to foster excellence in...
Stellate DNA LLC received a $256,000 National Science Foundation Project Grant under the NSF Technology, Innovation, and Partnerships program to develop a novel class of molecular vehicles for the targeted and precise integration of specified genetic information into the genomes of host cells and organisms. The one-year award runs from July 2021 through November 2022 and supports research to advance science and engineering leading to breakthrough technologies and solutions to national...